Singh Gurdev Dave 13D/13G Filings for Vivos Therapeutics, Inc. (VVOS)

Singh Gurdev Dave 13D and 13G filings for Vivos Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2022-02-14
5:02 pm
Purchase		 2021-12-31 13G Vivos Therapeutics, Inc.
VVOS		 Singh Gurdev Dave 129,988
14.100%		 1,200increase
(+0.93%)		 Filing
2021-02-16
2:34 pm
Purchase		 2020-12-31 13G Vivos Therapeutics, Inc.
VVOS		 Singh Gurdev Dave 128,788
17.700%		 128,788increase
(New Position)		 Filing